[go: up one dir, main page]

NO912071D0 - Fremstilling av anti-tumorforbindelser. - Google Patents

Fremstilling av anti-tumorforbindelser.

Info

Publication number
NO912071D0
NO912071D0 NO912071A NO912071A NO912071D0 NO 912071 D0 NO912071 D0 NO 912071D0 NO 912071 A NO912071 A NO 912071A NO 912071 A NO912071 A NO 912071A NO 912071 D0 NO912071 D0 NO 912071D0
Authority
NO
Norway
Prior art keywords
preparation
tumor compounds
tumor
compounds
Prior art date
Application number
NO912071A
Other languages
English (en)
Other versions
NO912071L (no
Inventor
Robert George Andrew
Andrew John Barker
Francis Thomas Boyle
James Michael Wardleworth
Original Assignee
Ici Plc
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10676728&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO912071(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ici Plc, Nat Res Dev filed Critical Ici Plc
Publication of NO912071D0 publication Critical patent/NO912071D0/no
Publication of NO912071L publication Critical patent/NO912071L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO91912071A 1990-05-30 1991-05-29 Fremgangsmaater for fremstilling av anti-tumorforbindelser NO912071L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9011989 1990-05-30

Publications (2)

Publication Number Publication Date
NO912071D0 true NO912071D0 (no) 1991-05-29
NO912071L NO912071L (no) 1991-12-02

Family

ID=10676728

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91912071A NO912071L (no) 1990-05-30 1991-05-29 Fremgangsmaater for fremstilling av anti-tumorforbindelser

Country Status (15)

Country Link
US (1) US5280027A (no)
EP (1) EP0459730A3 (no)
JP (1) JPH04235173A (no)
AU (1) AU640016B2 (no)
CA (1) CA2042922A1 (no)
CS (1) CS160591A3 (no)
FI (1) FI912600A7 (no)
GB (1) GB2244708B (no)
HU (1) HUT57739A (no)
IE (1) IE64085B1 (no)
IL (1) IL98167A0 (no)
NO (1) NO912071L (no)
NZ (1) NZ238259A (no)
PT (1) PT97799A (no)
ZA (1) ZA913730B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9220571D0 (en) * 1992-09-30 1992-11-11 Ici Plc Quinazoline derivatives
KR100284382B1 (ko) * 1995-08-22 2001-03-02 미즈노 마사루 아미드화합물 및 그의 용도
CA2184783A1 (en) * 1995-09-08 1997-03-09 William J. Gill Nonclassical antifolates
GB9904275D0 (en) * 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6518292B1 (en) * 1999-03-12 2003-02-11 Bristol-Myers Squibb Co. Heterocyclic aromatic compounds usefuls as growth hormone secretagogues
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6753428B2 (en) * 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
AU2003213092A1 (en) * 2002-02-15 2003-09-09 Smithkline Beecham Corporation Syntheses of quinazolinones
KR20050036911A (ko) * 2002-05-09 2005-04-20 싸이토키네틱스, 인코포레이티드 화합물들, 방법 및 조성물
WO2003097053A1 (en) 2002-05-09 2003-11-27 Cytokinetics, Inc. Compounds, compositions, and methods
JP2005536475A (ja) * 2002-05-23 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
WO2003106426A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
EP1537089A4 (en) * 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
AU2003262747A1 (en) * 2002-08-21 2004-03-11 Cytokinetics, Inc. Compounds, compositions, and methods
AU2003277079A1 (en) 2002-09-30 2004-05-04 Cytokinetics, Inc. Compounds, compositions, and methods
EP1682534A2 (en) * 2003-11-03 2006-07-26 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions, and methods
WO2005046588A2 (en) * 2003-11-07 2005-05-26 Cytokinetics, Inc. Compounds, compositions, and methods
WO2005061460A1 (en) * 2003-12-08 2005-07-07 Cytokinetics, Inc. Compounds, compositions, and methods
BRPI0813355A2 (pt) * 2007-06-22 2014-12-30 Arqule Inc Compostos de quinazolinona e métodos de uso dos mesmos
DE102010001064A1 (de) * 2009-03-18 2010-09-23 Bayer Schering Pharma Aktiengesellschaft Substituierte 2-Acetamido-5-Aryl-1,2,4-triazolone und deren Verwendung
CA2839703A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
AP2013007331A0 (en) 2011-06-24 2013-12-31 Amgen Inc TRPM8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
US10413583B2 (en) * 2016-11-30 2019-09-17 The University Of Chicago Synthetic substrates for enzymes that catalyze reactions of modified cysteines and related methods
AU2024277518A1 (en) * 2023-05-25 2025-11-27 Allorion Therapeutics Inc N-(1h-indol-2-yl)methyl)-4-ethynyl-picolinamide derivatives as egfr inhibitors for the treatment of cancer

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds

Also Published As

Publication number Publication date
IE64085B1 (en) 1995-07-12
GB9111656D0 (en) 1991-07-24
CA2042922A1 (en) 1991-12-01
HUT57739A (en) 1991-12-30
CS160591A3 (en) 1992-01-15
IL98167A0 (en) 1992-06-21
AU640016B2 (en) 1993-08-12
EP0459730A2 (en) 1991-12-04
NO912071L (no) 1991-12-02
JPH04235173A (ja) 1992-08-24
ZA913730B (en) 1992-02-26
EP0459730A3 (en) 1993-01-20
US5280027A (en) 1994-01-18
PT97799A (pt) 1992-02-28
FI912600A7 (fi) 1991-12-01
AU7707591A (en) 1991-12-05
NZ238259A (en) 1993-07-27
GB2244708B (en) 1993-12-08
FI912600A0 (fi) 1991-05-30
GB2244708A (en) 1991-12-11
IE911757A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
NO912071D0 (no) Fremstilling av anti-tumorforbindelser.
NO913234L (no) Fremgangsmaate for fremstilling av pyrazolderivater.
FI910978L (fi) Process foer preparation av kompositioner med multipla orienterade mesogener och flytande kristallpolymerfilmer och fibrar med multippel riktad orientering.
FI913101A0 (fi) Foerfarande foer framstaellning av blandningar av polysackarider med laog molekylvikt och anvaendning av dessa.
NO912346L (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
NO913008D0 (no) Fremgangsmaate for fremstilling av fenylacetamid-derivater.
NO911606D0 (no) Fremgangsmaate for fremstilling av glycidylazidpolymer.
NO892204D0 (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
FI913674A7 (fi) Med textilbaerband och sprutpressat spaerrorgan foersedd dragked och foerfarande foer framstaellning av en dylik dragked.
NO920049D0 (no) Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere
FI913175A7 (fi) Foerfarande foer framstaellning av polymerer och kopolymerer med laog optisk taethet foer fotoresist- och optiska anvaendningar.
NO914053L (no) Fremgangsmaate for fremstilling av 8-klorokinolonderivater
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO893143D0 (no) Fremstilling av klordioksyd.
FI913889A7 (fi) Foerfarande och en med toemningsanordning foersedd enplanspress foer samtidig tillverkning av tvao dekorationslaminatskivor.
NO914985L (no) Fremgangsmaate for fremstilling av 15-nitro-tabersonin-derivater
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO914452L (no) Fremgangsmaate for fremstilling av isokinolinderivater
FI913285A0 (fi) Svavelsubstituerade mevinsyraderivat.
NO901462D0 (no) Skjoeting av konstruksjonselementer.
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
FI913414A0 (fi) Foerfarande foer framstaellning av 2-hydroxi-3-halogen-5-nitropyridiner.
FI911959A7 (fi) Luckring av fraestorv.
FI862198A0 (fi) Foerfarande foer ytbelaeggning av en traematerialskiva och en skiva med en ytbelaeggning.
FI900589A0 (fi) Reglering av koldioxidhalten i atmosfaeren.